ABCB1 rs4148740: Understanding This Pharmacogenetic Variant
The rs4148740 variant is a single nucleotide polymorphism located within the ABCB1 gene, which encodes a protein responsible for transporting molecules across cell membranes. Research investigates whether this variant influences how the body processes certain medications, though clinical evidence remains limited and sometimes conflicting.
What each genotype means
Typical ABCB1 transporter activity
This genotype represents the most common form of this genetic variant. Research into this specific SNP is limited, and while the ABCB1 gene is known to influence drug transport, there is no definitive evidence that this specific genotype significantly alters clinical outcomes. Please discuss any concerns regarding medication response or dosing with your clinician or pharmacist.
This is the most frequently observed genotype across most global populations.
Typical ABCB1 transporter activity
You carry one copy of the variant allele for this SNP. Current scientific literature indicates that the clinical impact of this specific variant remains unclear, with conflicting reports regarding its role in drug response. You should consult with your healthcare provider or pharmacist regarding any questions about your medication efficacy or potential side effects.
This heterozygous genotype is commonly found in diverse populations worldwide.
Typical ABCB1 transporter activity
You carry two copies of the variant allele for this SNP. While the ABCB1 gene is critical for drug transport, studies on this specific variant have not established a clear or consistent clinical effect on drug response. Please consult your clinician or pharmacist to discuss your specific health context and any medication-related questions.
This genotype is less common than the CC or CT genotypes in most studied populations.
What is rs4148740?
The rs4148740 variant is a specific change in the DNA sequence of the ABCB1 gene, located on chromosome 7. In genetics, a single nucleotide polymorphism (SNP) like rs4148740 represents a variation at a single position in the genome. This particular SNP is often studied as part of a larger linkage block, meaning it is frequently inherited alongside other nearby genetic variations. Because it sits within a gene that is highly active in various tissues, researchers have long been interested in whether this specific site contributes to the functional differences observed in how individuals respond to various therapeutic drugs. It is important to note that while this variant is cataloged in major databases, its presence alone does not determine a clinical outcome, as drug response is a complex trait influenced by many genetic and environmental factors.
The Role of the ABCB1 Gene
The ABCB1 gene, also known as the MDR1 gene, provides instructions for creating a protein called P-glycoprotein. This protein functions as an ATP-dependent efflux pump, which acts like a biological gatekeeper by moving various substances, including toxins and medications, out of cells. P-glycoprotein is particularly important at the blood-brain barrier, where it helps regulate the concentration of substances entering the central nervous system. By limiting the entry of certain compounds into the brain, this protein plays a critical role in pharmacokinetics—the way the body absorbs, distributes, and eliminates drugs. Variations in the ABCB1 gene may theoretically alter the expression or efficiency of this pump, potentially leading to differences in the amount of medication that reaches its target site or remains in the bloodstream.
Research and Clinical Evidence
Scientific research into rs4148740 has primarily focused on its potential impact on drug efficacy and side effects, particularly in the context of antidepressants and other medications that cross the blood-brain barrier. While some small-scale studies have suggested that certain ABCB1 variants might correlate with treatment outcomes, the evidence for rs4148740 specifically is considered limited. Large-scale trials, such as the iSPOT-D study, have examined ABCB1 genetic effects on antidepressant outcomes, but results across the broader scientific literature have often been conflicting or inconsistent. Because of this, the variant is not currently used as a standard clinical predictor for medication dosing. The complexity of drug metabolism means that even if a variant has a measurable effect in a laboratory setting, it may not translate into a clinically significant difference for an individual patient in a real-world medical environment.
Interpreting Your Genetic Information
If you have received information about your rs4148740 genotype, it is essential to understand that this data is for educational purposes and should not be used to make medical decisions. Genetic variants are only one piece of a much larger puzzle that includes your overall health, other medications you may be taking, and your unique physiology. You cannot and should not use this information to start, stop, or change the dosage of any prescribed medication. If you are curious about how your genetics might influence your response to a specific treatment, the most appropriate step is to have a conversation with your healthcare provider or a clinical pharmacist. They are equipped to interpret genetic information in the context of your full medical history and can provide guidance based on established clinical guidelines rather than isolated genetic markers.
How common is this variant?
The global minor allele frequency for rs4148740 is approximately 0.13, though frequencies can vary significantly across different ancestral populations.
Frequently asked questions
Can I use rs4148740 to predict if an antidepressant will work for me?
No. While researchers have studied ABCB1 variants in relation to antidepressant response, the evidence is inconsistent and not strong enough to be used as a clinical tool for predicting how well a medication will work for an individual.
Is rs4148740 a diagnostic test for drug resistance?
No, this variant is not a diagnostic test. Drug response is influenced by many genes, environmental factors, and health conditions, and no single SNP can reliably predict how a person will respond to a drug.
Should I change my medication based on my ABCB1 genotype?
You should never change your medication or dosage based on genetic test results without consulting your doctor. Only a healthcare professional can safely evaluate your treatment plan.
Where can I find more information about pharmacogenomics?
You can visit resources like PharmGKB or MedlinePlus Genetics for reliable, evidence-based information on how genes affect drug response. These sites provide summaries of current scientific understanding.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4148740?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCB1
This variant is studied for its influence on the pharmacokinetics of immunosuppressive drugs like cyclosporine and tacrolimus in transplant patients.
Synonymous variant (c.3435C>T) in ABCB1 linked to altered P-glycoprotein expression and multi-drug transporter pharmacokinetics.
Nonsynonymous variant in ABCB1 altering P-glycoprotein transporter kinetics.
A variant associated with potential differences in drug absorption and clinical outcomes in patients undergoing specific pharmacological therapies.
This SNP is linked to variations in the pharmacokinetics of drugs that are substrates for the ABCB1 transporter protein.
Synonymous polymorphism in the ABCB1 (MDR1) transporter gene influencing substrate drug efflux and systemic drug exposure.